Jane Street’s Orion Biotech Opportunities Corp. Units ORIAU Stock Holding History

Jane Street’s Portfolio ORIAU Stock Details ORIAU Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q4	–	Sell	-373,804	Closed	-$3.68M	–	10536
2022 Q3	$3.68M	Buy	373,804 +2,640	+0.7%	+$26K	﹤0.01%	3122
2022 Q2	$3.66M	Sell	371,164 -180	-0%	-$1.77K	﹤0.01%	3132
2022 Q1	$3.63M	Sell	371,344 -60	-0%	-$589	﹤0.01%	3596
2021 Q4	$3.68M	Buy	371,404 +600	+0.2%	+$5.97K	﹤0.01%	3353
2021 Q3	$3.68M	Buy	370,804 +63	+0%	+$629	﹤0.01%	3274
2021 Q2	$3.73M	Buy	+370,741	New	+$3.74M	﹤0.01%	3165

Other funds holding ORIAU

JNE Partners London, United Kingdom $244M AUM 15.73% 1-Year Est. Return

SIA

Schechter Investment Advisors Birmingham, Michigan $1.21B AUM 8.73% 1-Year Est. Return

GAM

Gritstone Asset Management Bethesda, Maryland $93.6M AUM 11.18% 1-Year Est. Return

6CM

683 Capital Management New York $1.92B AUM 85.52% 1-Year Est. Return

Clear Street New York $24.6B AUM 56.26% 1-Year Est. Return

UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return

Jane Street's ORIAU Position: Q4 2022 in Review

Jane Street sold out of Orion Biotech Opportunities Corp. Units (ORIAU) in Q4 2022, closing a stake of 373,804 shares — an estimated $3.68M sold.

Jane Street first reported a position in ORIAU in Q2 2021 and held it in 6 quarters. The position peaked at $3.73M in Q2 2021. 6 funds tracked by Wall St. Rank hold ORIAU as of Q4 2022.

Jane Street reported no remaining Orion Biotech Opportunities Corp. Units position as of Q4 2022 after selling out during the quarter.
Jane Street sold 373,804 Orion Biotech Opportunities Corp. Units shares in Q4 2022, an estimated $3.68M.
Jane Street first reported a position in Orion Biotech Opportunities Corp. Units in Q2 2021 and held it in 6 quarters.
Jane Street's Orion Biotech Opportunities Corp. Units position peaked at $3.73M in Q2 2021.
6 funds tracked by Wall St. Rank held Orion Biotech Opportunities Corp. Units as of Q4 2022.

Based on Jane Street's 13F filing for Q4 2022, filed 15 Feb 2023.